-
公开(公告)号:US20240124389A1
公开(公告)日:2024-04-18
申请号:US18495200
申请日:2023-10-26
Applicant: FUJIFILM Corporation
Inventor: Shintaro TANABE , Tatsuya NITABARU , Mashiko YAMAMOTO , Hirofumi FUKUNAGA , Naoto NAKAMURA , Noriyuki KASAGI , Taisuke ENDO , Keiko SUZUKI
IPC: C07C229/26 , A61K9/127 , C07C229/28
CPC classification number: C07C229/26 , A61K9/127 , C07C229/28
Abstract: An object of present invention is to provide a compound or a salt thereof constituting lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids, and to provide lipid particles and pharmaceutical composition using the compound or a salt thereof, which can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids. According to an aspect of the present invention, a compound represented by Formula (1) or a salt thereof is provided.
In the formula, each symbol has a meaning defined in the present specification.-
公开(公告)号:US20220096381A1
公开(公告)日:2022-03-31
申请号:US17457793
申请日:2021-12-06
Applicant: FUJIFILM Corporation
Inventor: Taisuke ENDO , Shun KANEUMI , Masaki NORO , Shintaro TANABE , Masahiko YAMAMOTO
Abstract: An object of the present invention is to provide a lipid composition making it possible to achieve excellent delivery of nucleic acids. According to the present invention, there is provided a lipid composition containing a lipid represented by Formula (1) or a salt thereof, a nonionic lipid, a lipid having a nonionic hydrophilic polymer structure, and a nucleic acid, in which the lipid composition contains or does not contain a zwitterionic lipid, and in a case where (A) represents a molar ratio in percentage of the lipid represented by Formula (1) or a salt thereof to total lipids constituting the lipid composition and (B) represents a molar ratio in percentage of the zwitterionic lipid to total lipids constituting the lipid composition, (A) and (B) satisfy 40
-
公开(公告)号:US20190314335A1
公开(公告)日:2019-10-17
申请号:US16448069
申请日:2019-06-21
Applicant: FUJIFILM Corporation
Inventor: Yuta YOSHINO , Hayato OGURA , Mikinaga MORI , Taisuke ENDO , Kentaro NUMAJIRI , Ritsuko HORI
IPC: A61K31/4045 , A61K9/127 , A61K35/00
Abstract: An object of the present invention is to provide a lipid particle composition containing panobinostat or a salt thereof and exhibiting a high bone marrow-targeting capability, and a pharmaceutical composition including the lipid particle composition. According to the present invention, provided is a lipid particle composition containing panobinostat or a salt thereof, in which a lipid particle contains a phospholipid and cholesterol.
-
公开(公告)号:US20220273817A1
公开(公告)日:2022-09-01
申请号:US17743584
申请日:2022-05-13
Applicant: FUJIFILM Corporation
Inventor: Takahiro SEKIGUCHI , Taisuke ENDO , Shun KANEUMI , Masaki NORO , Shintaro TANABE , Masahiko YAMAMOTO
Abstract: An object of the present invention is to provide a lipid composition capable of achieving excellent nucleic acid delivery for a wide variety of nucleic acids. According to the present invention, there is provided a lipid composition containing a first lipid which is a lipid represented by Formula (1) or a salt thereof, sterols, and nucleic acid, in which a ratio of the number of moles of the first lipid in the lipid composition to the number of moles of sterols in the lipid composition is 0.300 or more and less than 1.299. In the formula, X represents —NR1— or —O—, R1 represents a hydrogen atom, a hydrocarbon group, or the like, R2 and R3 each independently represent a hydrogen atom, a hydrocarbon group, or the like, R4, R5, R6, R7, R8, R9, R10, R11, and R12 each independently represent a hydrogen atom or an alkyl group, groups in any one or more pairs among R4 and R5, R10 and R5, R5 and R12, R4 and R6, R5 and R6, R6 and R7, R6 and R10, R12 and R7, and R7 and R8 may be linked to each other to form a 4- to 7-membered ring which may contain an O atom, a, b, c, and d are each independently represent an integer of 0 to 3, a+b is 1 or more, and c+d is 1 or more.
-
公开(公告)号:US20190070123A1
公开(公告)日:2019-03-07
申请号:US16183738
申请日:2018-11-08
Applicant: FUJIFILM CORPORATION
Inventor: Satoshi YONEYAMA , Taisuke ENDO
IPC: A61K9/70 , A61K31/496 , A61K47/12 , A61K47/14 , A61K47/20
Abstract: Provided is a transdermal preparation including: a phenylpiperazine derivative; an organic acid; an ester-based solvent; and an organic sulfoxide.
-
公开(公告)号:US20240315970A1
公开(公告)日:2024-09-26
申请号:US18443959
申请日:2024-02-16
Applicant: FUJIFILM Corporation
Inventor: Shintaro TANABE , Masahiko YAMAMOTO , Kimihiko SATO , Motomasa TAKAHASHI , Kazuhiro TSUNA , Yasutaka TASAKI , Taisuke ENDO , Issei DOI , Hirofumi FUKUNAGA
IPC: A61K9/127 , C07C219/06 , C12N15/88
CPC classification number: A61K9/1272 , A61K9/1278 , C07C219/06 , C12N15/88
Abstract: An object of the present invention is to provide a compound or a salt thereof constituting lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids, and to provide lipid particles that can achieve a high nucleic acid encapsulation rate and excellent delivery of nucleic acids. According to an aspect of the present invention, a compound represented by Formula (1) or a salt thereof is provided.
In the formula, X represents —NR1— or —O—, R1 represents a hydrogen atom, a hydrocarbon group, or the like, R2 and R3 each independently represent a hydrogen atom, a hydrocarbon group, or the like, R4, R5, R6, R7, R8, R9, R10, R11, and R12 each independently represent a hydrogen atom or an alkyl group,
groups in any one or more pairs among R4 and R5, R10 and R5, R5 and R12, R4 and R6, R5 and R6, R6 and R7, R6 and R10, R12 and R7, and R7 and R8 may be linked to each other to form a 4- to 7-membered ring which may contain an O atom, a, b, c, and d are each independently represent an integer of 0 to 3, a+b is equal to or greater than 1, and c+d is equal to or greater than 1.
-
-
-
-
-